期刊文献+

三氧化二砷和维生素C联合诱导喉癌细胞Hep-2凋亡的作用 被引量:3

Effects of vitamin C comined with arsenic trioxide on the apoptosis of Hep-2 cell
原文传递
导出
摘要 目的:研究三氧化二砷(As2O3)与维生素C联用对喉癌细胞(Hep-2)凋亡的协同作用。方法:As2O3及联用VitC孵育体外培养的人Hep-2,采用四甲基偶氮唑蓝(MTT)法测定细胞存活率,Annexin-V/PI双染色流式细胞术观察各组细胞凋亡变化。结果:As2O3与VitC联用能显著降低单用As2O3的细胞存活率(P<0.05),同时VitC能显著增强As2O3诱导细胞凋亡作用(P<0.01)。结论:联用VitC能增强As2O3诱导Hep-2凋亡的作用。 Objective: To study synergistic effect of Vitamin C (VitC) combined with arsentic trioxide (As2O3)-on human laryngocarcinoma Hep-2 cell line apoptosis. Method: Human laryngocarcinoma cell line Hep-2 was cultured in vitro, and incubated with As2O3 or jointly with VitC. The inhibition ability of Hep-2 cells was detemined by methyl thiazolyl tetrazolium (MTT) assay, while the apoptosis was mensurated by the flow cytometry with Annexin-V/PI. Result:Compared with the use of As2O3 separately, the combination of As2O3 and VitC could increase the inhibition ability and the apoptosis rate of Hep-2 cells markedly (P〈0.05). Conclusion: Combination of As2 O3 with VitC could markedly increase arsentic trioxide (As2 O3)-induced apoptosis of Hep-2 cells.
出处 《临床耳鼻咽喉头颈外科杂志》 CAS CSCD 北大核心 2008年第4期171-173,共3页 Journal of Clinical Otorhinolaryngology Head And Neck Surgery
关键词 喉肿瘤 三氧化二砷 维生素C 细胞凋亡 Laryngeal neoplasms Arsenic trioxide Vitamin C Apoptosis
  • 相关文献

参考文献9

  • 1DUCW, WENBG, LIDR, etal. Arsenic trioxide reduces the invasive and metastatic properties of nasopharyngeal carcinoma cells in vitro[J]. Braz J Med Biol Res, 2006,39:677-685.
  • 2刘济生,杨吉成,盛伟华,肖根生.三氧化二砷诱导喉癌Hep-2细胞凋亡的初步研究[J].苏州大学学报(医学版),2003,23(3):289-291. 被引量:2
  • 3GRAHAM-EVANS B, COHLY H H, YU H, et al.Arsenic-induced genotoxic and cytotoxic effects in human keratinocytes, melanocytes and dendritic cells [J].Int J Environ Res Public Health, 2004,1 : 83 - 89.
  • 4高飞,易静,史桂英,李慧,石学耕,王志伟,汤雪明.维生素C增强氧化砷联用二甲萘醌诱导的U937细胞凋亡及其机制[J].中华血液学杂志,2002,23(1):9-11. 被引量:17
  • 5徐梦麒,陆德炎,徐瑞容.维生素C与三氧化二砷联用诱导K562细胞株凋亡的研究[J].南通医学院学报,2002,22(4):386-387. 被引量:6
  • 6DE ANDRES L, BRUNET J, LOPEZ-POUSA A, et al. Function p reservation in stage Ⅲ squamous laryngeal carcinoma: results with an induction chemotherapy protocol[J]. Laryngoscope, 1995,105:822- 826.
  • 7ANDREW M E, MARTIN S T, RONALD B G. The potential of arsenic trioxide in the treatment of malignant disease: past, present, and future[J].Leuk Res,2004,28:891-900.
  • 8CASCIARI J J, RIORDAN N H, SCHMIDT T L, et al. Cytotoxicity of ascorbate, lipoic acid, and other antioxidants in hollow fibre in vitro tumours[J]. Br J Cancer, 2001,84 : 1544-1550.
  • 9KANGJ H, SHI Y M, ZHENG R L. Effects of ascorbic acid on humanhepatoma cell proliferation and redifferentiation[J]. Zhongguo Yao Li Xue Bao,1999, 20:1019--1024.

二级参考文献19

  • 1[1]Hu Y,Su L,Snow ET.Arsenic toxicity is enzyme specific and its effects on ligation are not caused by the direct inhibition of DNA repair enzymes[J]. Mutat Res, 1998,408(3)∶203.
  • 2[2]Zhang W,Ohnishi K,Shigeno K,et al.The induction of apoptosis and cell cycle arrest by arsenic trioxide in lymphoid neoplasms[J].Leukemia, 1998,12(9)∶1383.
  • 3[3]Dai J,Weinberg RS,Waxman S.Malignant cells can be sensitized to undergo growth inhibition and apoptosis by arsenic trioxide throgh modulation of the glutathione redox system[J]. Blood, 1999,93(1)∶268.
  • 4[4]Perkins C,Kim CN.Arsenic induces apoptosis of multidrug-resistant human myeloid leukemia cells that express Bcr-Ab1 of overexpress MDR,MRP,Bcl-2,or Bcl-x(L)[J].Blood,2000,95(3)∶1014.
  • 5[5]Costantini P,Belzacq AS,Vieira HL,et al.Oxidation of a critical thiol residue of the adenine nucleotide translocator enforces Bcl-2-independent permeability transition pore opening and apoptosis[J]. Oncogene,2000,19(2)∶307.
  • 6[6]Muller S,Miller WH Jr,Dejean A.Trivalent antimonials induce degradation of the PML-RAR oncoprotein and reorganization of the promyelocytic leukemia nuclear bodies in acute promyelocytic leukemia NB4 cells[J].Blood,1998,92(11)∶4308.
  • 7[7]Song JH,Shin SH,Ross GM.Oxidative stress induced by ascorbate causes neuronal damage in an in vitro system[J]. Brain Res,2001,859(1~2)∶66.
  • 8[8]Riordan NH,Riordan HD,Meng X,et al.Intravenous ascorbate as a tumor cytotoxic chemotherapeutic agent[J].Med Hypotheses,1995,44(3)∶207.
  • 9Shen ZX, Chen GQ, Ni JH, et al. Use of arsenic trioxide(As2Ch) in the treatment of acute promyelocytic leukemia(APL):Ⅱ. Clinical efficacy and pharmacokinetics in replased patients[J ]. Blood, 1997, 89(9) :3354--3360.
  • 10Seol JG, Park WH, Kim ES, et al. Effect of arsenic trioxide on cell cycle arrest in head and neck cancer cell linePCI-1 [J ]. Biochem Biophys Res Commun, 1999, 265(2) : 400-- 404.

共引文献17

同被引文献40

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部